By Leslie A. Pappas
July 2, 2024, 7:40 PM EDT
A California-based biotech company once researching a new class of antiviral therapy for COVID-19 is now the subject of dissolution proceedings in Delaware’s Court of Chancery, after the company’s two directors…
Source: https://www.law360.co.uk/amp/articles/1854469